MedTrace Logo

Evaluation of an Oral Nutritional Supplement

NCT01781624 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2013-02-01

No results posted yet for this study

Summary

The objective of this study is to evaluate gastrointestinal tolerance of an oral nutritional supplement containing a new protein blend in healthy elderly subjects.

Conditions

  • Gastro-intestinal Tolerance

Interventions

OTHER

Study Oral Nutritional Supplement

Supplement contains a new protein mix consisting of a blend of milk, soy, and pea protein.

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • Jeffrey Nelson, PhD · Abbott Nutrition

Study Design

Allocation
NON_RANDOMIZED
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
60 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01781624 on ClinicalTrials.gov